(Q37896674)

25 August 2017

1 reference

title

Emergence and spread of antibiotic resistance following exposure to antibiotics (English)

1 reference

25 August 2017

antibiotic resistance

1 reference

Rafael Cantón

1

1 reference

PubMed ID

21722146

25 August 2017

María-Isabel Morosini

series ordinal

2

1 reference

25 August 2017

29 July 2011

1 reference

FEMS Microbiology Reviews

25 August 2017

1 reference

25 August 2017

35

1 reference

25 August 2017

5

1 reference

25 August 2017

977-991

1 reference

The intrinsic resistome of Pseudomonas aeruginosa to β-lactams.

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

21 January 2018

Evolving promiscuously

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Gene amplification and adaptive evolution in bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Persistence of antibiotic resistance in bacterial populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic heterogeneity: from concept to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Low-level antibacterial resistance: a gateway to clinical resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

From pieces to patterns: evolutionary engineering in bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The 2010 Garrod Lecture: the dimensions of evolution in antibiotic resistance: ex unibus plurum et ex pluribus unum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Selective compartments for resistant microorganisms in antibiotic gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic cycling or rotation: a systematic review of the evidence of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Multi-resistant Gram-negative bacilli: from epidemics to endemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case-control study in a French teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The role of mutators in the emergence of antibiotic-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Side effects of antibiotics on genetic variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The mutant selection window in rabbits infected with Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Sampling the antibiotic resistome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Expanding the soil antibiotic resistome: exploring environmental diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Biofilms: survival mechanisms of clinically relevant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Increased mutability of Pseudomonas aeruginosa in biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Ciprofloxacin dosage and emergence of resistance in human commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Correlation between rates of carbapenem consumption and the prevalence of carbapenem-resistant Pseudomonas aeruginosa in a tertiary care hospital in Brazil: a 4-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Bacterial biofilms: from the natural environment to infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutagenesis induced by 12 quinolone antibacterial agents in Escherichia coli WP2uvrA/pKM101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic resistance of bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial ag

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Joint effects of topoisomerase alterations and plasmid-mediated quinolone-resistant determinants in Salmonella enterica Typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Clinical implications of antimicrobial resistance for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

21 January 2018

Antibiotic heterogeneity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Breakpoints: current practice and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Characterization of the GO system of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Tetracycline-resistant Escherichia coli strains are inherited from parents and persist in the infant's intestines in the absence of selective pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Clinical significance of extended-spectrum beta-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The interface between veterinary and human antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Prevention and treatment of Staphylococcus biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The 2009 Garrod lecture: the evolution of antimicrobial resistance: a Darwinian perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Setting and revising antibacterial susceptibility breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Antibiotic rotation and development of gram-negative antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Correlation between fluoroquinolone consumption in hospitals and ciprofloxacin resistance amongst Pseudomonas aeruginosa isolates causing healthcare-associated infections, Taiwan, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

A unified anti-mutant dosing strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2011.00295.X

10.1111/J.1574-6976.2011.00295.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21722146